While precision oncology requires robust biomarkers, current predictors for lung adenocarcinoma (LUAD) often show limited clinical utility. This study investigates the multifaceted roles of ZC3H12D, a ...

Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society ...

I never thought in a million years that this would happen to me … especially so young,” Brooklynite Jaclyn Keely told The ...

Bramel recently retired and is now in the fight of his life, facing a diagnosis of renal cell carcinoma in his lungs.

Ariel Lopez-Chavez, MD, medical oncologist, director of precision medicine and developmental therapeutics at Allegheny Health Network Cancer Institute, discusses comprehensive genomic profiling and ...

About 59,080 new cases of ductal carcinoma in situ (DCIS ... Breast cancer is the second leading cause of cancer death in women. (Only lung cancer kills more women each year.) The chance that any ...

Belrestotug showed underwhelming efficacy outcomes in mid-stage studies of non-small cell lung cancer and head and neck ...

Lung cancer is a leading cause of cancer deaths around the world, and is often not diagnosed until it is in late stages that are frequently untreatable... | Cell And Molecular Biology ...

SAN ANTONIO - There is new technology in the fight against the spread of lung cancer.And it comes in the form of a robot, ...

Janux Therapeutics, Inc.’s JANX share price has dipped by 7.22%, which has investors questioning if this is right time to buy ...